4.5 Article

Relationship between gut microbiota and vascular calcification in hemodialysis patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Nutrition & Dietetics

Diet Quality and Protein-Bound Uraemic Toxins: Investigation of Novel Risk Factors and the Role of Microbiome in Chronic Kidney Disease

Catherine McFarlane et al.

Summary: This study suggests that diet quality may influence uremic toxin generation and gut microbiota diversity, composition, and function in CKD patients.

JOURNAL OF RENAL NUTRITION (2022)

Article Urology & Nephrology

Correlation between intestinal flora disruption and protein-energy wasting in patients with end-stage renal disease

Jianguang Hu et al.

Summary: This study examined the effects of different dialysis treatments on the composition and structure of the intestinal flora in chronic kidney disease (CKD) patients. The results showed that butyric acid-producing bacteria were positively correlated with protein-energy wasting (PEW) and negatively correlated with Escherichia. Improving intestinal diversity and increasing the amount of butyric acid-producing bacteria are potential therapeutic approaches to enhance protein-energy consumption in CKD patients with end-stage renal disease (ESRD).

BMC NEPHROLOGY (2022)

Article Immunology

Uremic Toxin-Producing Bacteroides Species Prevail in the Gut Microbiota of Taiwanese CKD Patients: An Analysis Using the New Taiwan Microbiome Baseline

Subhashree Shivani et al.

Summary: This study examined the gut microbiota of a healthy Taiwanese population and identified specific bacterial species associated with different demographics. Compared to healthy controls, dialysis patients showed significant differences in gut microbiota composition. The most abundant genus in CKD patients was Bacteroides, and specific species such as B. ovatus, B. caccae, B. uniformis were more abundant in hemodialysis patients, while Blautia producta was more abundant in peritoneal dialysis patients. The study also found enriched pathways related to the production of uremic toxins in CKD patients.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Biochemistry & Molecular Biology

Vascular Calcification and the Gut and Blood Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Pilot Study

Ana Merino-Ribas et al.

Summary: This pilot study aimed to explore the link between gut and blood microbiomes and vascular calcification (VC) in peritoneal dialysis (PD) patients with chronic kidney disease (CKD-PD). The results showed relative changes in specific taxa between CKD-PD patients with and without VC in gut and blood microbiomes. There was also an association between VC and all-cause mortality risk in CKD-PD patients, with changes in certain microbial groups observed in the gut and blood. Therefore, certain microbial groups in the gut, blood, and circulating sCD14 may serve as biomarkers for VC, cardiovascular disease (CVD), and mortality risk in CKD.

BIOMOLECULES (2022)

Review Medicine, General & Internal

TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis

Luigina Guasti et al.

Summary: The study indicates a significant association between high TMAO levels and cardiovascular events as well as all-cause mortality, suggesting it may be a new CVD risk factor.

INTERNAL AND EMERGENCY MEDICINE (2021)

Article Transplantation

Metagenomic profiling of gut microbiome in early chronic kidney disease

Noriaki Sato et al.

Summary: By analyzing the differences in gut microbiome between diabetic and non-diabetic participants, the study found subtle changes in the gut microbiome of individuals with early CKD, with alterations related to short-chain fatty acid production already observable in early stages of CKD.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Review Cell Biology

Role of gut microbiota-derived metabolites on vascular calcification in CKD

Li Yin et al.

Summary: This review focuses on how the gut microbiota and their metabolites affect vascular calcification in chronic kidney disease, and how dietary modification and probiotics can be used to correct the imbalance in gut microbiota for innovative treatment options.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Medicine, Research & Experimental

A comparative study of acarbose, vildagliptin and saxagliptin intended for better efficacy and safety on type 2 diabetes mellitus treatment

Zhongchao Wang et al.

Summary: The study compared the efficacy and safety of acarbose, saxagliptin, and vildagliptin in treating T2DM, finding that these drugs can effectively reduce HbA1c levels and impact the distribution of intestinal flora in patients with T2DM. Adverse reactions were higher with saxagliptin compared to acarbose and vildagliptin, suggesting alternative strategies for the treatment of T2DM.

LIFE SCIENCES (2021)

Review Medicine, General & Internal

Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease

Fernanda G. Rodrigues et al.

Summary: This article explores the deregulation of gut microbiota in patients with chronic kidney disease (CKD) and its impact on vascular and bone diseases. It discusses the influence of diet, medications, and other factors on gut microbiota composition and subsequently on the overall health of CKD patients.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Multidisciplinary Sciences

Compositional change of gut microbiome and osteocalcin expressing endothelial progenitor cells in patients with coronary artery disease

Takumi Toya et al.

Summary: This study found an association between gut dysbiosis, TMAO levels, immature OCN-expressing EPCs levels, and CAD, suggesting that gut microbiome-derived systemic inflammation may mediate the harmful effects of immature OCN-expressing EPCs on CAD.

PLOS ONE (2021)

Article Immunology

The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses

Dan Luo et al.

Summary: Alterations in gut microbiota were observed in end-stage renal disease (ESRD) patients with or without dialysis. Dialysis reversed abnormal changes in certain bacterial genera in pre-dialysis patients. Functional predictions of microbial communities showed that peritoneal dialysis (PD) and hemodialysis (HD) altered signal transduction and metabolic pathways in ESRD patients. Certain gut bacteria were associated with cardiovascular mortality and peritonitis in ESRD patients. This study suggested a potential impact of gut bacteria on patient prognosis.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Review Gastroenterology & Hepatology

Gut Bacteroides species in health and disease

Hassan Zafar et al.

Summary: The functional diversity of the mammalian intestinal microbiome far exceeds that of the host organism, and microbial genes contribute substantially to the well-being of the host; beneficial gut organisms can also be pathogenic when present in the gut or other locations in the body; Bacteroides metabolize polysaccharides and oligosaccharides, providing nutrition and vitamins to the host and other intestinal microbial residents.

GUT MICROBES (2021)

Review Medicine, General & Internal

Vascular calcification of chronic kidney disease: A brief review

Bang-Gee Hsu et al.

Summary: Vascular calcification is common in patients with chronic kidney disease and may be related to abnormal mineral metabolism, with regulation of vascular smooth muscle cell differentiation into osteogenic cells. There are various imaging modalities for evaluating VC, and while there is no universally accepted treatment method, medical therapy may be beneficial for the condition.

TZU CHI MEDICAL JOURNAL (2021)

Article Urology & Nephrology

High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients

Jianguang Hu et al.

BMC NEPHROLOGY (2020)

Review Biochemistry & Molecular Biology

Dietary Protein and Gut Microbiota Composition and Function

Jianfei Zhao et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2019)

Article Urology & Nephrology

Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance

Britt Opdebeeck et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Article Multidisciplinary Sciences

Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide

Matthew T. Henke et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Cardiac & Cardiovascular Systems

An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil

Kyle L. Flannigan et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)

Review Cell Biology

Gut microbiota derived metabolites in cardiovascular health and disease

Zeneng Wang et al.

PROTEIN & CELL (2018)

Article Urology & Nephrology

Abdominal aortic calcification in patients with CKD

Mieke J. Peeters et al.

JOURNAL OF NEPHROLOGY (2017)

Article Urology & Nephrology

Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients

Tariq Shafi et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Article Multidisciplinary Sciences

Alteration of the gut microbiota in Chinese population with chronic kidney disease

Shuanghong Jiang et al.

SCIENTIFIC REPORTS (2017)

Review Microbiology

Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction

Yael Litvak et al.

CURRENT OPINION IN MICROBIOLOGY (2017)

Article Endocrinology & Metabolism

Inflammation and the bone-vascular axis in end-stage renal disease

L. Viaene et al.

OSTEOPOROSIS INTERNATIONAL (2016)

Article Peripheral Vascular Disease

Inflammatory Cytokines and Reactive Oxygen Species as Mediators of Chronic Kidney Disease-Related Vascular Calcification

Mohsen Agharazii et al.

AMERICAN JOURNAL OF HYPERTENSION (2015)

Review Urology & Nephrology

The Gut Microbiome, Kidney Disease, and Targeted Interventions

Ali Ramezani et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Review Nutrition & Dietetics

Regulation of Inflammation by Short Chain Fatty Acids

Marco A. R. Vinolo et al.

NUTRIENTS (2011)

Article Transplantation

Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease

Sophie Liabeuf et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)

Article Urology & Nephrology

Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients

Fellype C. Barreto et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)